Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bayer Aktienges ADR (OP: BAYRY )

6.230 UNCHANGED
Streaming Delayed Price Updated: 3:59 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bayer Aktienges ADR

< Previous 1 2 3 4 5 6 Next >
Agricultural Technology Companies Are Finding Themselves in a Global Race to Develop and Acquire New Intellectual Property
Image by AgriFORCE The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga... 
Via Benzinga
The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Adcom Recommends Approval Of Moderna's COVID-19 Vaccine Booster Shot For... 
Via Benzinga
Exposures COVID-19 Product Safety
Here’s What Happens When You Beat The Market By 5% (And How To Do It)
See, the way Wall Street makes money has fundamentally shifted in recent years. So has the way information flows to individual investors. And today I want to show you how savvy stock pickers can profit... 
Via Talk Markets
I See Another “Chipotle Moment”
Lawsuits are terrible for business. They bring distractions, extra costs, and uncertainty. Big Tobacco knows this all too well. 
Via Talk Markets
Topics Lawsuit
Exposures Financial Legal
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Acceleron Stock Heats Up On $11 Billion Takeover Rumor; So, Who's The Buyer?
A biotech working in lung and blood diseases, as well as cancer, could be acquired. 
Via Investor's Business Daily
BWXT Medical, Bayer AG Ink Agreement On Actinium-225
BWX Technologies Inc's (NYSE: BWXT) subsidiary BWXT Medical Ltd. has agreed with Bayer AG (OTC: BAYRY) to develop Actinium-225 (Ac-225) supply and... 
Via Benzinga
Regeneron Touts Mid-Stage Win For Higher Dose Of Eylea In Age-related Macular Degeneration
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) revealed new Phase 2 proof-of-concept trial data on Eylea (aflibercept) injection in patients with wet age-related... 
Via Benzinga
Berkeley Lights, Bayer Ink Discovery Pact For Next-Gen Traits In Agricultural Sector, Berkeley Q2 Earnings Miss Estimates
Berkeley Lights Inc (NASDAQ: BLI) reports Q2 sales of $19.3 million, +82% Y/Y, but slightly missing the consensus of $19.64 million. The Company expanded the installed... 
Via Benzinga
Topics Earnings
Exposures Financial
3 Pharma Stocks to Buy in August
These stocks offer solid growth opportunities. 
Via The Motley Fool
Bristol Myers Pulls Accelerated Approval For Opdivo In Post-Nexavar Liver Cancer
Bristol Myers Squibb & Co (NYSE: BMY) on Friday said it's voluntarily withdrawing Opdivo's approval in hepatocellular carcinoma (HCC) patients who... 
Via Benzinga
The Cloud Sector Can Drive Your Profits Sky High
If you hear someone suggesting you invest in “containers,” please don’t get confused. Most folks would naturally think of these as giant metal shipping boxes that are integral for global trade. 
Via Talk Markets
Merck - Bayer's Heart Failure Treatment, Verquvo Scores European Nod
The European Commission (EC) has approved Merck & Co Inc's (NYSE: MRK) soluble guanylate cyclase (sGC) stimulator Verquvo (vericiguat). Verquvo... 
Via Benzinga
Bayer's Kerendia Scores Long-Awaited Kidney & Heart Disease Nod For Type 2 Diabetes
The FDA on Friday approved Bayer AG's (OTC: BAYRY) chronic kidney disease (CKD) drug Kerendia (finerenone), the first and only nonsteroidal mineralocorticoid... 
Via Benzinga
Exposures Product Safety
3 Top Biotech Stocks to Buy in July
Now's the time to get into these companies while their valuation is still favorable. 
Via The Motley Fool
3 Big Drugmakers to Buy Ahead of the Q2 Earnings Season
The big drug companies are set for the second-quarter earnings season, which begins later this month. 
Via Talk Markets
Cloud Stocks Change Name Of The Cloud Computing Game With 'Containers' From Amazon, Microsoft, Alphabet's Google
Amazon, Microsoft and Google are promoting a model that may expand cloud computing. 
Via Investor's Business Daily
Why Did Novocure Shares Plunge Today?
Novocure Ltd (NASDAQ: NVCR) has announced final results from its phase 2 pilot HEPANOVA trial evaluating Tumor Treating Fields (TTFields) together with Bayer... 
Via Benzinga
Exelixis Shares Drop On Mixed Results For Cabometyx Combo In Early Liver Cancer
Exelixis Inc (NASDAQ: EXEL) and Ipsen (OTC: IPSEY) have announced mixed interim results from the COSMIC-312 Phase 3 trial evaluating cabozantinib (... 
Via Benzinga
Bayer's Cell, Gene Therapies for Parkinson's Disease Enters Human Trials
Bayer AG’s (OTC: BAYRY) Parkinson’s disease stem cell therapy has officially landed in the clinic, while another treatment for the neurodegenerative... 
Via Benzinga
Bayer Buys Two Biotech Firms to Beef Up Radiopharmaceuticals
Bayer AG (OTC: BAYRY) will acquire two small biotech companies in a deal that adds an experimental prostate cancer medicine to the German drugmaker's pipeline... 
Via Benzinga
Bayer Mulls Ending US Retail Sales Of Weedkiller Glyphosate: Reuters
A U.S. judge rejected Bayer AG’s (OTC: BAYRY) plan to try and limit the cost of future class action claims that its Roundup weedkiller causes cancer, saying that... 
Via Benzinga
Exposures Glyphosate
Artificial Intelligence Doctor App Ada Health Closes $90M Funding Led By Bayer, Samsung
German digital health firm Ada Health has raised a $90 million funding round at an undisclosed valuation bringing total investment in the company up to around $150... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.